| Not Yet Recruiting | The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio NCT07476248 | Assiut University | — |
| Not Yet Recruiting | Evaluating The Roles of Novel Inflammatory Markers Compared to MCP-1 in Type 2 Diabetic Nephropathy NCT07173686 | Assiut University | — |
| Enrolling By Invitation | Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Pa NCT07038213 | Astana Medical University | — |
| Not Yet Recruiting | Assessement of the Knoweldge ,Attitudes,Practices of Diabetic Kidney Disease Among Diabetic Patients NCT06927921 | Assiut University | — |
| Enrolling By Invitation | Type 2 Diabetes and Associated Factors in Mexico NCT07248891 | Coordinación de Investigación en Salud, Mexico | — |
| Not Yet Recruiting | Comparative Effectiveness Of Low Extra-Corporeal Shock Wave Versus Acetylcholine Iontophoresis On Type2 Diabet NCT06482021 | South Valley University | N/A |
| Completed | MMP-9/NGAL Modulation by Piper Crocatum in Early Diabetic Nephropathy NCT06676124 | Hasanuddin University | N/A |
| Recruiting | The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy NCT06843304 | Chinese PLA General Hospital | — |
| Recruiting | A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy NCT06661174 | China-Japan Friendship Hospital | — |
| Unknown | Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease NCT05330390 | The Second Hospital of Shandong University | — |
| Unknown | The Expression of circANKRD36 as a New Biomarker of Diabetic Nephropathy NCT05061459 | Assiut University | — |
| Completed | Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Pati NCT04981613 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Completed | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects NCT05492630 | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| Recruiting | Raman Spectroscopy Diagnosis of Kidney Diseases NCT06760845 | Zunsong Wang | — |
| Completed | Enhanced Recovery After Surgery for SPK Transplantation Recipients NCT06095544 | Second Affiliated Hospital of Guangzhou Medical University | N/A |
| Completed | Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. NCT04027530 | Amsterdam UMC, location VUmc | Phase 4 |
| Unknown | Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy NCT04562025 | Renmin Hospital of Wuhan University | N/A |
| Completed | Pain Neuroscience Education in Diabetic Neuropathy NCT04721847 | Riphah International University | N/A |
| Unknown | Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagno NCT06123871 | Yipeng Liu | — |
| Unknown | Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnosti NCT06097351 | Yipeng Liu | — |
| Unknown | Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy NCT04125329 | Yan'an Affiliated Hospital of Kunming Medical University | EARLY_Phase 1 |
| Unknown | Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes NCT04127084 | Zhongshan Hospital Xiamen University | Phase 4 |
| Completed | Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy NCT05695573 | Tanta University | — |
| Unknown | Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapor NCT03413215 | Changi General Hospital | N/A |
| Completed | Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy NCT03804879 | Novartis Pharmaceuticals | Phase 2 |
| Unknown | Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy NCT03658317 | Assiut University | N/A |
| Completed | Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy NCT03436693 | Tanabe Pharma Corporation | Phase 3 |
| Completed | Telmisartan Promotes the Differentiation of Monocytes Into Macrophages M2 in Diabetic Nephropathy? NCT02768948 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Di NCT02502071 | University of Colorado, Denver | Phase 4 |
| Completed | CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea NCT02816762 | Hospital Universitario La Paz | Phase 4 |
| Completed | Effect of Pirfenidone on Glomerular Filtration Rate and Albuminuria in Patients With Diabetic Nephropathy NCT02689778 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 3 |
| Completed | Resveratrol's Effects in Diabetic Nephropathy NCT02704494 | Shiraz University of Medical Sciences | EARLY_Phase 1 |
| Completed | An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy NCT02676401 | Tanabe Pharma Corporation | Phase 2 |
| Completed | Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic P NCT02625649 | University of Aarhus | — |
| Unknown | Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy) NCT02409511 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Completed | Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy NCT02628106 | West China Hospital | Phase 4 |
| Completed | Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes NCT02914691 | Peter Rossing | Phase 4 |
| Completed | Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes NCT02928250 | Ain Shams University | N/A |
| Completed | Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy NCT02517320 | Tanabe Pharma Corporation | Phase 2 |
| Withdrawn | Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macr NCT02410499 | Takeda | Phase 2 |
| Completed | A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria NCT02345057 | Daiichi Sankyo | Phase 2 |
| Unknown | Mechanisms of Diabetic Nephropathy in Ecuador NCT02237352 | Universidad Estatal de Milagro | — |
| Unknown | The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy NCT02501772 | Mackay Memorial Hospital | N/A |
| Completed | Microalbuminuria and Allopurinol in Type 1 Diabetes NCT02829177 | Peter Rossing | Phase 4 |
| Completed | Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients NCT02251067 | Vascular Pharmaceuticals, Inc. | Phase 2 |
| Completed | Effect of LIXIsenatide on the Renal System NCT02276196 | Amsterdam UMC, location VUmc | Phase 4 |
| Completed | The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy NCT02204280 | Hebei Medical University Third Hospital | — |
| Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy NCT02205372 | Tanabe Pharma Corporation | Phase 1 / Phase 2 |
| Terminated | Pyridorin in Diabetic Nephropathy NCT02156843 | NephroGenex, Inc. | Phase 3 |
| Completed | Effect of Low GI/ Glycemic Load (GL) Diet in Diabetic Nephropathy Patients NCT02384902 | Isfahan University of Medical Sciences | N/A |
| Completed | The Differential Effects of Diabetes Therapy on Inflammation NCT02150707 | University College Dublin | — |
| Completed | A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, NCT04881994 | Bayer | Phase 1 |
| Completed | Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopa NCT02040441 | Peter Rossing | Phase 2 / Phase 3 |
| Completed | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NCT02065791 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Ayurvedic Management of Chronic Kidney Disease NCT02477163 | J.S. Ayurveda College | N/A |
| Unknown | SWIDINEP a Swiss Diabetic Nephropathy Cohort NCT03407989 | Centre Hospitalier Universitaire Vaudois | — |
| Unknown | Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria NCT02035891 | Chongqing Medical University | N/A |
| Completed | Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy. NCT01923597 | University of Campinas, Brazil | Phase 2 |
| Completed | To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy NCT01935167 | Dong Wha Pharmaceutical Co. Ltd. | Phase 2 |
| Completed | Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy NCT01889277 | Tanabe Pharma Corporation | Phase 1 / Phase 2 |
| Completed | Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy NCT01843387 | Mesoblast, Ltd. | Phase 1 / Phase 2 |
| Terminated | Study Of Diabetic Nephropathy With Atrasentan NCT01858532 | AbbVie | Phase 3 |
| Completed | Study of LY3016859 in Participants With Diabetic Nephropathy NCT01774981 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Unknown | Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy NCT01796418 | Seoul National University Hospital | N/A |
| Completed | Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study) NCT01869881 | Yuhan Corporation | Phase 4 |
| Recruiting | Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID) NCT01802034 | The Rogosin Institute | — |
| Completed | A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In NCT01712061 | Pfizer | Phase 2 |
| Completed | Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting. NCT02194790 | Bhumirajanagarindra Kidney Institute, Thailand | N/A |
| Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic NCT01756716 | Tanabe Pharma Corporation | Phase 2 |
| Completed | A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic NCT01756703 | Tanabe Pharma Corporation | Phase 2 |
| Unknown | Prevention of Renal Complications of Diabetes With Thiamine NCT01725412 | University of Saskatchewan | Phase 4 |
| Completed | Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy NCT01726816 | Korea Otsuka Pharmaceutical Co., Ltd. | Phase 2 |
| Unknown | Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diab NCT01673204 | Seoul National University Hospital | Phase 4 |
| Unknown | Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diab NCT01743014 | AHEPA University Hospital | Phase 4 |
| Completed | Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients NCT01601236 | Mallinckrodt | Phase 2 |
| Completed | Renal Denervation in Diabetic Nephropathy NCT01588795 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Unknown | Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slow NCT01566006 | The Nazareth Hospital, Israel | N/A |
| Completed | The Effects of Sevelamer Carbonate on Diabetic Nephropathy NCT01493050 | Gary Striker | Phase 2 |
| Unknown | Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease NCT01458158 | Aristotle University Of Thessaloniki | — |
| Completed | A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy NCT01447147 | Amgen | Phase 2 |
| Completed | Vitamin D Supplementation in Diabetic Nephropathy NCT01476501 | University of Alberta | Phase 2 |
| Completed | A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and A NCT01440257 | Amgen | Phase 2 |
| Completed | A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasent NCT01399580 | AbbVie (prior sponsor, Abbott) | Phase 2 |
| Completed | Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan NCT01424319 | AbbVie (prior sponsor, Abbott) | Phase 2 |
| Completed | Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to NCT01356849 | AbbVie (prior sponsor, Abbott) | Phase 2 |
| Completed | Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499 NCT01328821 | Concert Pharmaceuticals | Phase 1 |
| Unknown | Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients NCT01316068 | Sun Yat-sen University | Phase 4 |
| Completed | N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy NCT01265563 | VA Office of Research and Development | Phase 2 |
| Completed | Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy NCT01371955 | University Hospital, Grenoble | — |
| Suspended | Molecular and Clinical Profile of Diabetes Mellitus and Its Complications NCT01105858 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy NCT01003236 | Shiraz University of Medical Sciences | Phase 2 |
| Unknown | An Investigation on the Effect of Candesartan on Early Diabetic Nephropathy NCT01273675 | National Taiwan University Hospital | — |
| Completed | Effects of PH3 in Diabetic Nephropathy NCT01068041 | PhytoHealth Corporation | Phase 2 |
| Terminated | A Study in Participants With Diabetic Kidney Disease NCT01113801 | Eli Lilly and Company | Phase 2 |
| Completed | The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes Mellitus NCT01130727 | University of Campinas, Brazil | N/A |
| Completed | Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure NCT01667614 | Tehran University of Medical Sciences | Phase 2 |
| Completed | Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy NCT01331317 | Peter Rossing | Phase 4 |
| Completed | A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients Wit NCT01252056 | Otsuka Beijing Research Institute | Phase 4 |
| Unknown | Colchicine for Diabetic Nephropathy NCT01005121 | Prof.Avi Livneh | Phase 2 |
| Terminated | Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney NCT01129557 | Columbia University | Phase 4 |
| Withdrawn | Flavonoids in the Treatment of Endothelial Dysfunction in Children With Diabetes NCT01307917 | Texas Tech University Health Sciences Center | N/A |
| Completed | A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin Sy NCT00920764 | AbbVie (prior sponsor, Abbott) | Phase 2 |
| Completed | Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy NCT00967629 | Icahn School of Medicine at Mount Sinai | Phase 1 |
| Completed | Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN) NCT01028287 | Southeast Renal Research Institute | Phase 4 |
| Completed | Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidn NCT00811889 | Biogen | Phase 2 |
| Unknown | Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus. NCT01215994 | AHEPA University Hospital | — |
| Unknown | Aldosterone in Diabetic Nephropathy NCT00870402 | Universidad de los Andes, Chile | Phase 4 |
| Terminated | Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Th NCT00913393 | Kyntra Bio | Phase 2 |
| Unknown | Minocycline and Proteinuria in Diabetic Nephropathy NCT01779089 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | N/A |
| Completed | To Assess the Accuracy of the eZscan Study in the Screening for Diabetic Nephropathy NCT01163591 | Chinese University of Hong Kong | — |
| Completed | Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes NCT00734253 | NephroGenex, Inc. | Phase 2 |
| Completed | Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic Nep NCT00664027 | Biogen | Phase 2 |
| Completed | Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic Nephropathy NCT00754143 | Kyntra Bio | Phase 1 |
| Completed | Effect of Turmeric on Diabetic Nephropathy NCT01015937 | Shaheed Faghihi Hospital | N/A |
| Completed | FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients NCT01703234 | Gulhane School of Medicine | Phase 4 |
| Completed | Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) L NCT00893425 | Gulhane School of Medicine | Phase 4 |
| Completed | Benfotiamine in Diabetic Nephropathy NCT00565318 | University Medical Center Groningen | Phase 4 |
| Terminated | Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria NCT00557518 | Synvista Therapeutics, Inc | Phase 2 |
| Unknown | Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study NCT00497666 | Assaf-Harofeh Medical Center | — |
| Unknown | Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program NCT00498147 | Group Health Centre | — |
| Completed | To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) NCT00518362 | Nanjing University School of Medicine | N/A |
| Completed | Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) NCT00708981 | Cook County Health | N/A |
| Terminated | Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong NCT00462202 | Keryx Biopharmaceuticals | Phase 3 |
| Completed | Adiponectin and Insulin Resistance in Diabetic Nephropathy NCT00774904 | Xi'an Jiaotong University | N/A |
| Completed | Adiponectin in Obese Women With T2DN and Effects by RAS Blocker NCT00561704 | Shanghai Jiao Tong University School of Medicine | N/A |
| Completed | The Effects of Bindarit in Diabetic Nephropathy NCT01109212 | Aziende Chimiche Riunite Angelini Francesco S.p.A | Phase 2 |
| Completed | Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephro NCT00738660 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 3 |
| Completed | Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects NCT00544934 | Glycadia | Phase 1 / Phase 2 |
| Completed | Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy NCT00556465 | Shiraz University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Eplerenone, ACE Inhibition and Albuminuria NCT00315016 | Radboud University Medical Center | Phase 2 |
| Completed | The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being NCT00421733 | Abbott | Phase 2 |
| Completed | Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progr NCT00363987 | Fresenius Kabi | Phase 4 |
| Completed | Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy NCT00312780 | Symphony Evolution, Inc. | Phase 2 |
| Completed | Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinur NCT00663949 | Shiraz University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria NCT00287183 | Pfizer | Phase 2 |
| Completed | Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy NCT00361023 | Shanghai Jiao Tong University School of Medicine | N/A |
| Completed | Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy NCT00253786 | Okayama University | N/A |
| Completed | Nephropathy In Type 2 Diabetes and Cardio-renal Events NCT00535925 | University of Campania Luigi Vanvitelli | Phase 4 |
| Completed | Effect of Sulodexide in Early Diabetic Nephropathy NCT00130208 | Keryx Biopharmaceuticals | Phase 3 |
| Terminated | Effect of Sulodexide in Overt Diabetic Nephropathy NCT00130312 | Keryx Biopharmaceuticals | Phase 4 |
| Terminated | To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Di NCT00120328 | Speedel Pharma Ltd. | Phase 3 |
| Completed | Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) NCT00296296 | Stanford University | Phase 4 |
| Completed | Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease NCT00118976 | Steno Diabetes Center Copenhagen | N/A |
| Completed | Pioglitazone and Losartan Provides Additional Renoprotection NCT00364988 | Shanghai Jiao Tong University School of Medicine | N/A |
| Completed | Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy NCT00914524 | Daiichi Sankyo Co., Ltd. | Phase 2 |
| Completed | Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients. NCT01875341 | Ottawa Hospital Research Institute | Phase 3 |
| Completed | Antiproteinuric Effect of Valsartan and Lisinopril NCT00171574 | Novartis | Phase 4 |
| Completed | SLC2A1 Variants and Diabetic Nephropathy NCT01768611 | University of Sao Paulo General Hospital | — |
| Completed | Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in P NCT00097955 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy NCT00782847 | DiaNe HCM GmbH | Phase 3 |
| Completed | Enhancing Adherence in Type 2 Diabetes: The ENHANCE Study NCT00222846 | University of Pittsburgh | N/A |
| Completed | Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes NCT00419484 | Dokkyo Medical University | — |
| Terminated | A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Vals NCT00171119 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease. NCT00240019 | Stanford University | N/A |
| Completed | Spironolactone in Diabetic Nephropathy NCT00317954 | Steno Diabetes Center Copenhagen | Phase 4 |
| Completed | Pirfenidone: A New Drug to Treat Kidney Disease in Patients With Diabetes NCT00063583 | Sharma, Kumar, M.D. | Phase 1 / Phase 2 |
| Completed | Olmesartan Medoxomil and Diabetic Nephropathy NCT00362960 | Sankyo Pharma Gmbh | Phase 3 |
| Terminated | Treatment of Diabetic Nephropathy NCT00065559 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial NCT00141453 | Daiichi Sankyo Co., Ltd. | Phase 3 |
| Completed | Matrix Metalloproteinases and Diabetic Nephropathy NCT00067886 | Arkansas Children's Hospital Research Institute | — |
| Completed | Chicken-Diet vs. Enalapril to Reduce Albuminuria NCT00484068 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | Spironolactone for Reducing Proteinuria in Diabetic Nephropathy NCT00498537 | US Department of Veterans Affairs | N/A |
| Completed | Angiotensin II Antagonism of TGF-Beta 1 NCT00320970 | Providence Health & Services | N/A |
| Completed | The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes NCT00044148 | Chromaderm, Inc. | Phase 2 |
| Completed | Effect of Pyridorin in Patients With Diabetic Nephropathy NCT00320021 | BioStratum | Phase 2 |
| Completed | European Trial of Immunosuppression in SPK Tx NCT00140543 | EUROSPK Study Group | Phase 3 |
| Completed | Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney NCT00106561 | Melbourne Health | Phase 2 / Phase 3 |
| Completed | Effect of Pyridorin in Patients With Diabetic Nephropathy NCT00320060 | BioStratum | Phase 2 |
| Completed | Soy Protein in Early Diabetic Nephropathy NCT00067678 | National Center for Complementary and Integrative Health (NCCIH) | Phase 1 / Phase 2 |
| Recruiting | Family Investigation of Nephropathy and Diabetes (F.I.N.D.) NCT00342927 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | The Family Investigation of Nephropathy and Diabetes Study NCT00301249 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Renoprotection in Early Diabetic Nephropathy in Pima Indians NCT00340678 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Delaying the Progression of Diabetic Nephropathy in Pima Indians NCT00353600 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Sex-specific Association With Kidney Disease NCT01810822 | University of Sao Paulo General Hospital | — |
| Completed | Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes NCT00004266 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy NCT00311870 | Steno Diabetes Center Copenhagen | Phase 4 |
| Completed | Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) NCT00594152 | Joslin Diabetes Center | Phase 3 |
| Completed | Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or NCT02327754 | Sanwa Kagaku Kenkyusho Co., Ltd. | Phase 2 |
| Completed | The Genetics of Kidneys in Diabetes (GoKinD) Study NCT00024921 | National Center for Research Resources (NCRR) | — |